EP2861234
PROGESTERONE FORMULATIONS
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
18.6.2013EP published:
27.3.2019EP application number:
13807121.2
EPO information:
European Patent Register
Max expiry date:
17.6.2033
Title:
PROGESTERONE FORMULATIONS
Timeline
Today
18.6.2013EP application
27.3.2019EP Publication
Owner
Name:
TherapeuticsMD, Inc.Address:
6800 Broken Sound Parkway NW 3rd Floor, 33487, Boca Raton, FL, US
Inventor
Name:
CACACE, Janice LouiseAddress:
St Petersburg, FL, US
Name:
PERSICANER, Peter H.R.Address:
Boca Raton, Florida, US
Priority
Number:
201261661302 PDate:
18.6.2012Country:
US
Number:
201261662265 PDate:
20.6.2012Country:
US
Number:
201213684002Date:
21.11.2012Country:
US
Number:
PCT/US2013/023309Date:
25.1.2013Country:
WO
Number:
201313843362Date:
15.3.2013Country:
US
Classification
Categories:
A61K 31/57, A61K 31/565, A61K 47/14, A61K 45/06, A61K 47/10, A61K 9/107, A61K 9/48